Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes. A Systematic Literature Review and Meta-Analysis

Linda van Eikenhorst, Katja Taxis, Liset van Dijk, Han de Gier, Linda van Eikenhorst, Katja Taxis, Liset van Dijk, Han de Gier

Abstract

Background: Treatment of diabetes requires a strict treatment scheme which demands patient self-management. Pharmacists are in a good position to provide self-management support. This review examines whether pharmacist-led interventions to support self-management in diabetes patients improve clinical and patient-reported outcomes. Methods: This review was conducted according to the PRISMA guidelines. An extended literature search was conducted with the keywords "pharmacist," "diabetes," and "self-management" using the electronic databases Pubmed, Embase, CINAHL, PsycINFO, Web of Science, and the Cochrane Library from the beginning of the database through September 2017. In addition reference lists of systematic reviews and included studies were searched. Eligibility criteria included; self-management intervention tested with an RCT, performed in an ambulatory care setting, led by a pharmacist and reporting at least one clinical- or patient-reported outcome. Primary outcomes were HbA1c (-as this is a clinical parameter for long-term diabetes follow-up), self-management and components of intervention. Secondary outcomes were blood glucose, blood pressure, BMI, lipids, adherence to medication, quality of life, and diabetes knowledge. For the meta-analysis HbA1c values were pooled with a random-effects model in Revman 5.3. Risk of bias was assessed with the Cochrane Risk of Bias tool. Results: Twenty-four studies representing 3,610 patients were included. Pharmacist-led self-management interventions included education on diabetes complications, medication, lifestyle, and teaching of self-management skills. Some studies focused on patient needs through a tailored intervention. No key components for a successful self-management intervention could be identified. Pharmacist-led self-management interventions improve HbA1c levels with a mean of 0.71% (CI -0.91, -0.51; overall effect P < 0.0001) and had a positive effect on blood pressure (SBP -5.20 mm Hg [-7.58; -2.92], DBP -3.51 mmHg [-6.00; -1.01]), BMI (-0.49 kg/m2 [-0.79; -0.19]), lipids (total cholesterol -0.19 mmol/l [-0.33; -0.05], LDL-C mmol/l -0.16 [-0.26; -0.06], HDL-C 0.32 mmol/l [0.02; 0.61]), self-management skill development, and adherence to medication. Conclusion: Pharmacist-led self-management interventions significantly improve HbA1c values in diabetes patients. These results underline the added value of pharmacists in patient-related care. Pharmacists should offer self-management support to diabetes patients in order to improve diabetes outcomes.

Keywords: HbA1c; diabetes; meta-analysis; pharmacist; pharmacy practice; self-management.

Figures

Figure 1
Figure 1
Flow chart study selection.
Figure 2
Figure 2
Meta-analysis HbA1c.
Figure 3
Figure 3
Pooled results SDSCA categories.

References

    1. Armour C. L., Taylor S. J., Hourihan F., Smith C., Krass I. (2004). Implementation and evaluation of Australian pharmacists' diabetes care services. J. Am. Pharm. Assoc. 44, 455–466. 10.1331/1544345041475625
    1. Barlow J. (2001). How to use education as an intervention in osteoarthritis. Best Pract. Res. Clin. Rheumatol. 15, 545–558. 10.1053/berh.2001.0172
    1. Barlow J., Wright C., Sheasby J., Turner A., Hainsworth J. (2002). Self-management approaches for people with chronic conditions: a review. Patient Educ. Couns. 48, 177–187. 10.1016/S0738-3991(02)00032-0
    1. Bodenheimer T., Lorig K., Holman H., Grumbach K. (2002). Patient self-management of chronic disease in primary care. JAMA 288, 2469–2475. 10.1001/jama.288.19.2469
    1. Bos-Touwen I., Schuurmans M., Monninkhof E. M., Korpershoek Y., Spruit-Bentvelzen L., Ertugrul-van der Graaf I., et al. . (2015). Patient and disease characteristics associated with activation for self-management in patients with diabetes, chronic obstructive pulmonary disease, chronic heart failure and chronic renal disease: a cross-sectional survey study. PLoS ONE 10:e0126400. 10.1371/journal.pone.0126400
    1. Butt M., Mhd Ali A., Bakry M. M., Mustafa N. (2015). Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: a randomised controlled study. Saudi Pharm. J. 24, 40–48. 10.1016/j.jsps.2015.02.023
    1. Cameron K. A., Ross E. L., Clayman M. L., Bergeron A. R., Federman A. D., Bailey S. C., et al. . (2010). Measuring patients' self-efficacy in understanding and using prescription medication. Patient Educ. Couns. 80, 372–376. 10.1016/j.pec.2010.06.029
    1. Cani C. G., Lopes Lda S., Queiroz M., Nery M. (2015). Improvement in medication adherence and self-management of diabetes with a clinical pharmacy program: a randomized controlled trial in patients with type 2 diabetes undergoing insulin therapy at a teaching hospital. Clinics 70, 102–106. 10.6061/clinics/2015(02)06
    1. Capoccia K., Odegard P. S., Letassy N. (2016). Medication adherence with diabetes medication: a systematic review of the literature. Diabetes Educ. 42, 34–71. 10.1177/0145721715619038
    1. Choe H. M., Mitrovich S., Dubay D., Hayward R. A., Krein S. L., Vijan S. (2005). Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am. J. Manag. Care 11, 253–260.
    1. Cohen L. B., Taveira T. H., Khatana S. A., Dooley A. G., Pirraglia P. A., Wu W. C. (2011). Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educ. 37, 801–812. 10.1177/0145721711423980
    1. Doucette W. R., Witry M. J., Farris K. B., McDonough R. P. (2009). Community pharmacist-provided extended diabetes care. Ann. Pharmacother. 43, 882–889. 10.1345/aph.1L605
    1. Farsaei S., Sabzghabaee A. M., Zargarzadeh A. H., Amini M. (2011). Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J. Res. Med. Sci. 16, 43–49.
    1. Fransen M. P., Beune E. J., Baim-Lance A. M., Bruessing R. C., Essink-Bot M. L. (2015). Diabetes self-management support for patients with low health literacy: perceptions of patients and providers. J. Diabetes 7, 418–425. 10.1111/1753-0407.12191
    1. Fransen M. P., von Wagner C., Essink-Bot M. (2012). Diabetes self-management in patients with low health literacy: ordering findings from literature in a health literature framework. Patient Educ. Couns. 88, 44–53. 10.1016/j.pec.2011.11.015
    1. Greer N., Bolduc J., Geurkink E., Rector T., Olson K., Koeller E., et al. (2016). Pharmacist-led chronic disease management: a systematic review of effectiveness and harms compared with usual care. Ann. Intern. Med. 165, 30–40. 10.7326/M15-3058
    1. Harrington N. G., Noar S. M. (2012). Reporting standards for studies of tailored interventions. Health Educ. Res. 27, 331–342. 10.1093/her/cyr108
    1. Haugbolle L. S., Westh Sorensen E. (2006). Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma - interviewing patients at home. Pharm. World Sci. 28, 239–247. 10.1007/s11096-006-9023-9
    1. Hepler C. D., Strand L. M. (1990). Opportunities and responsibilities in pharmaceutical care. Am. J. Hosp. Pharm. 47, 533–543.
    1. Higgins J. P. T., Green S. (2011). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available online at: .
    1. Jacobs M., Sherry P. S., Taylor L. M., Amato M., Tataronis G. R., Cushing G. (2012). Pharmacist assisted medication program enhancing the regulation of diabetes (PAMPERED) study. J. Am. Pharm. Assoc. 52, 613–621. 10.1331/JAPhA.2012.10183
    1. Jahangard-Rafsanjani Z., Sarayani A., Nosrati M., Saadat N., Rashidian A., Hadjibabaie M., et al. . (2015). Effect of a community pharmacist-delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Diabetes Educ. 41, 127–135. 10.1177/0145721714559132
    1. Jameson J. P., Baty P. J. (2010). Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am. J. Manag. Care 16, 250–255.
    1. Jarab A. S., Alqudah S. G., Mukattash T. L., Shattat G., Al-Qirim T. (2012). Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J. Manag. Care Pharm. 18, 516–526. 10.18553/jmcp.2012.18.7.516
    1. Kelly M. P., Noyes J., Kane R. L., Chang C., Uhl S., Robinson K. A., et al. . (2017). AHRQ series on complex intervention systematic reviews – paper 2: defining complexity, formulating scope, and questions. J. Clin. Epidemiol. 90, 11–18. 10.1016/j.jclinepi.2017.06.012
    1. Kempen T. G., van de Steeg-van Gompel C. H., Hoogland P., Liu Y., Bouvy M. L. (2014). Large scale implementation of clinical medication reviews in Dutch community pharmacies: drug-related problems and interventions. Int. J. Clin. Pharm. 36, 630–635. 10.1007/s11096-014-9947-4
    1. Killip S., Mahfoud Z., Pearce K. (2004). What is an intracluster correlation coefficient? Crucial concepts for primary care research. Ann. Fam. Med. 2, 204–208. 10.1370/afm.141
    1. Kjeldsen L. J., Bjerrum L., Dam P., Larsen B. O., Rossing C., Sømdergaard B., et al. . (2015). Safe and effective use of medicines for patients with type 2 diabetes - A randomized controlled trial of two interventions delivered by local pharmacies. Res. Soc. Adm. Pharm. 11, 47–62. 10.1016/j.sapharm.2014.03.003
    1. Korcegez E. I., Sancar M., Demirkan K. (2017). Effect of a pharmacist-led program on improving outcomes in patients with type 2 diabetes mellitus from Northern Cyprus: a randomized controlled trial. J Manag Care Spec. Pharm. 23, 573–582. 10.18553/jmcp.2017.23.5.573
    1. Kraemer D. F., Kradjan W. A., Bianco T. M., Low J. A. (2012). A randomized study to assess the impact of pharmacist counseling of employer-based health plan beneficiaries with diabetes: the EMPOWER study. J. Pharm. Pract. 25, 169–179. 10.1177/0897190011418513
    1. Krass I., Armour C. L., Mitchell B., Brillant M., Dienaar R., Hughes J., et al. . (2007). The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet. Med. 24, 677–683. 10.1111/j.1464-5491.2007.02143.x
    1. Krass I., Mitchell B., Song Y. J. C., Stewart K., Peterson G., Hughes J., et al. . (2011). Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes. Diabetic Med. 28, 987–993. 10.1111/j.1464-5491.2011.03296.x
    1. Kreuter M. W., Wray R. J. (2003). Tailored and targeted health communication: Strategies for enhancing information relevance. Am. J. Health Behav. 27(Suppl. 3.), s227–s232. 10.5993/AJHB.27.1.s3.6
    1. Lin P., Kent D. M., Winn A. N., Cohen J. T., Neumann P. J. (2015). Multiple chronic conditions in type 2 diabetes mellitus: Prevalence and consequences. Am. J. Manag. Care 21, e23–e34.
    1. Linn A. J., van Weert J. C. M., Smit E. G., Perry K., van Dijk L. (2013). 1+1 = 3? The systematic development of a theoretical and evidence-based tailored multimedia intervention to improve medication adherence. Patient Educ Couns. 93, 381–388. 10.1016/j.pec.2013.03.009
    1. Linn A. J., Vervloet M., van Dijk L., Smit E. G., Van Weert J. C. M. (2011). Effects of eHealth interventions on medication adherence: a systematic review of the literature. J. Med. Internet Res. 13:e103. 10.2196/jmir.1738
    1. Luijks H., Schermer T., Bor H., van Weel C., Lagro-Janssen T., Biermans M., et al. . (2012). Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med. 10:128. 10.1186/1741-7015-10-128
    1. Machado M., Bajcar J., Guzzo G. C., Einarson T. R. (2007). Sensitivity of patient outcomes to pharmacist interventions. Part 1: ystematic review and meta-analysis in diabetes management. Ann Pharmacother. 41, 1569–1582. 10.1345/aph.1K311
    1. Mehuys E., Van Bortel L., De Bolle L., Van Tongelen I., Annemans L., Remon J. P., et al. . (2011). Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. J. Clin. Pharm. Ther. 36, 602–613. 10.1111/j.1365-2710.2010.01218.x
    1. Moher D., Liberati A., Tetzlaff J., Altman D., the PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 151, 264–269. 10.7326/0003-4819-151-4-200908180-00135
    1. Nascimento T., Braz N., Gomes E., Fernandez-Arche A., De La Puerta R. (2015). Self-care improvement after a pharmaceutical intervention in elderly type 2 diabetic patients. Curr. Diabetes Rev. 12, 120–128. 10.2174/1573399811666150722130232
    1. Newman S., Steed L., Mulligan K. (2004). Self-management interventions for chronic illness. Lancet 364, 1523–1537. 10.1016/S0140-6736(04)17277-2
    1. Noar S. M., Benac C. N., Harris M. S. (2007). Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychol. Bull. 133, 673–693. 10.1037/0033-2909.133.4.673
    1. Odegard P. S., Goo A., Hummel J., Williams K. L., Gray S. L. (2005). Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann. Pharmacother. 39, 433–440. 10.1345/aph.1E438
    1. Pousinho S., Morgado M., Falcao A., Alves G. (2016). Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials. J Manag. Care Spec. Pharm. 22, 493–515. 10.18553/jmcp.2016.22.5.493
    1. Samtia A. M., Rasool M. F., Ranjha N. M., Usman F., Javed I. (2013). A multifactorial intervention to enhance adherence to medications and disease-related knowledge in type 2 diabetic patients in Southern Punjab, Pakistan. Trop. J. Pharm. Res. 12, 851–856. 10.4314/tjpr.v12i5.28
    1. Sarkadi A., Rosenqvist U. (2004). Experience-based group education in Type 2 diabetes: a randomised controlled trial. Patient Educ. Couns. 53, 291–298. 10.1016/j.pec.2003.10.009
    1. Shao H., Chen G., Zhu C., Chen Y., Liu Y., He Y., et al. . (2017). Effect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus. Patient Prefer. Adher. 11, 897–903. 10.2147/PPA.S92533
    1. Sherifali D., Bai J. W., Kenny M., Warren R., Ali M. U. (2015). Diabetes self-management programme in older adults: a systematic review and meta-analysis. Diabet. Med. 32, 1404–1414. 10.1111/dme.12780
    1. Stratton I. M., Adler A. I., Neil H. A. W., Matthews D. R., Manley S. E., Cull C. A., et al. . (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321, 405–412. 10.1136/bmj.321.7258.405
    1. Struijs J. N., Baan C. A., Schellevis F. G., Westert G. P., van den Bos G. A. M. (2006). Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv. Res. 6:84. 10.1186/1472-6963-6-84
    1. Taveira T. H., Dooley A. G., Cohen L. B., Khatana S. A. M., Wu W. (2011). Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Ann. Pharmacother. 45, 1346–1355. 10.1345/aph.1Q212
    1. Taveira T. H., Friedmann P. D., Cohen L. B., Dooley A. G., Khatana S. A. M., Pirraglia P. A., et al. . (2010). Pharmacist-led group medical appointment model in type 2 diabetes. Diabetes Educ. 36, 109–117. 10.1177/0145721709352383
    1. Toobert D. J., Hampson S. E., Glasgow R. E. (2000). The summary of diabetes self-care activities measure. Diabetes Care 23, 943–950. 10.2337/diacare.23.7.943
    1. Viswanathan M., McPheeters M. L., Murad M. H., Butler M. E., Devine E. E., Dyson M. P., et al. . (2017). AHRQ series on complex intervention systematic reviews – paper 4: selecting analytic approaches. J. Clin. Epidemiol. 90, 28–36. 10.1016/j.jclinepi.2017.06.014
    1. Wiedenmayer K., Summers R. S., Mackie C. A., Gous A. G. S., Everard M., Tromp D. (2006). Developing Pharmacy practice. A Focus on Patient Care. World Health Organisation and International Pharmaceutical Federation.
    1. Wishah R. A., Al-Khawaldeh O. A., Albsoul A. M. (2015). Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: randomized controlled trial. Diabetes Metab. Syndr. 9, 271–276. 10.1016/j.dsx.2014.09.001
    1. World Health Organization (2016). Global Report on Diabetes. Available online at:

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera